Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrEP-001 for prevention of HRV-16 infection
NCT03338556Phase 2Completed
- Sponsor
- PrEP Biopharm
- Start
- Apr 2016
- Primary completion
- Sep 2016
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of polyinosine-polycytidylic acid in viral upper respiratory tract infection, sponsored by PrEP Biopharm. Started Apr 2016; status: completed.
02
Drugs
polyinosine-polycytidylic acid
03
Conditions
viral upper respiratory tract infection
Beyond the preview
Go deeper on NCT03338556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03338556.